Early studies show promising results for alcohol use disorder, with several clinical trials now exploring applications for other substance dependencies
The mTOR Pathway in Hearing Disorders: Mechanistic Links to Aging, Regeneration, and Neurodegeneration
Retatrutide is a triple receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, whereas semaglutide activates only the GLP-1 receptor and tirzepatide activates both GLP-1 and GIP receptors
These side effects are usually mild and go away as the body gets used to the drug
14 Finally, embarking on this journey with the guidance of a supportive healthcare team, including a physician and ideally a registered dietitian nutritionist, is strongly recommended
The safety and efficacy of N-acetylcysteine as an augmentation in the treatment of obsessive-compulsive disorder in adults: a systematic review and meta-analysis of randomized clinical trials